MedPath

Transcranial Magnetic Stimulation and Anti-epileptic Effect: Optimization and Evaluation With Electrophysiology.

Not Applicable
Completed
Conditions
Refractory Frontal Lobe Epilepsy
Registration Number
NCT00382707
Lead Sponsor
University Hospital, Strasbourg, France
Brief Summary

Epileptic disease is characterised by enhanced brain excitability. Low frequency repetitive transcranial magnetic stimulation (rTMS) can be an effective treatment for refractory frontal epilepsy. Thought, physiological mechanisms of its effectivity are still unknown. It is yet possible to evaluate cortical excitability and inhibition with TMS-coupled electromyography before and after rTMS sessions ; this could provide clues for basic mechanisms of rTMS effects on the epileptic brain. We assume that rTMS decrease brain excitability by improving brain inhibition. Such an information could help for treating patients with both pharmacological and non-pharmacological methods.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
15
Inclusion Criteria
  • Cryptogenic frontal lobe epilepsy
  • Normal cerebral MRI
Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Primary Outcome Measures
NameTimeMethod
Electrophysiological parameters for cortical excitability measured just before and after rTMS, 4 hours later and 24 hours later.
Secondary Outcome Measures
NameTimeMethod
Clinical efficacity on seizure intensity and frequency.

Trial Locations

Locations (2)

Département de Neurologie - Hôpital Civil

🇫🇷

Strasbourg, France

Institut de Physique Biologique

🇫🇷

Strasbourg, France

© Copyright 2025. All Rights Reserved by MedPath